Current strategies in the treatment of metastatic hormone-refractory prostate cancer

Tunis Med. 2005 Dec:83 Suppl 12:74.
No abstract available

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Antineoplastic Agents, Hormonal / therapeutic use*
  • Drug Resistance, Neoplasm*
  • Humans
  • Male
  • Neoplasm Staging
  • Palliative Care / methods*
  • Prostatic Neoplasms / drug therapy*
  • Prostatic Neoplasms / mortality
  • Survival Rate
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Antineoplastic Agents, Hormonal